BiotechTube
Home/Jocavio/Tomoko Inoue, Ph.D.
TI

Tomoko Inoue, Ph.D.

President and CEO

Jocavio

Therapeutic Areas

Oncology

Jocavio Pipeline

DrugIndicationPhase
Oncolytic Virus Therapy (undisclosed)Advanced Solid TumorsPreclinical

Leadership Team at Jocavio

HI
Hiroyuki Inoue, M.D., Ph.D.
Co-Founder, Physician Scientist
View full Jocavio profile